THIS AGREEMENT is made by and between TÁTO ZMLUVA sa uzatvára medzi 276/14Collaboration Agreement • December 2nd, 2014
Contract Type FiledDecember 2nd, 2014A Phase 3, Randomized, Double-Masked, Controlled Trial to Establish the Safety and Efficacy of Intravitreous Administration of Fovista™ (anti PDGF-B Pegylated Aptamer) Administered in Combination with Lucentis® Compared to Lucentis® Monotherapy in Subjects with Subfoveal Neovascular Age-Related Macular Degeneration (hereinafter Study)